October 27, 2018
2 min watch
Save

VIDEO: Abicipar yields positive results for long-term wet AMD treatment

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

CHICAGO ― At the American Academy of Ophthalmology meeting here, Rahul N. Khurana, MD, discusses results from the phase 3 study of abicipar for the treatment of wet age-related macular degeneration.